Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Dialog Solutions becomes Clarivate Dialog Solutions becomes Clarivate
Blog August 7, 2023
Dialog Solutions becomes Clarivate
Blog August 1, 2023
Clarivate Integrates Dialog Solutions Products and Services into Life Sciences & Healthcare Portfolio
The future of scRNA-Seq applicability The future of scRNA-Seq applicability
Blog July 6, 2023
The future of scRNA-Seq applicability
The AMJEVITA impact: Innovative U.S. biosimilar pricing models The AMJEVITA impact: Innovative U.S. biosimilar pricing models
Blog July 5, 2023
The AMJEVITA impact: Innovative U.S. biosimilar pricing models
Generative AI’s potential to speed delivery of improved patient outcomes Generative AI’s potential to speed delivery of improved patient outcomes
Blog June 29, 2023
Generative AI’s potential to speed delivery of improved patient outcomes
Regulators and HTAs tune in to patient preference data Regulators and HTAs tune in to patient preference data
Blog June 26, 2023
Regulators and HTAs tune in to patient preference data
Mind the gap: Using advanced analytics to find and fill the holes in real world data Mind the gap: Using advanced analytics to find and fill the holes in real world data
Blog June 22, 2023
Mind the gap: Using advanced analytics to find and fill the holes in real world data
Pharma-biotech partnerships take on new urgency as patent cliffs loom Pharma-biotech partnerships take on new urgency as patent cliffs loom
Blog May 31, 2023
Pharma-biotech partnerships take on new urgency as patent cliffs loom
Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges
Blog May 24, 2023
Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges
Mainland China’s regulatory evolution brings greater access to novel drugs Mainland China’s regulatory evolution brings greater access to novel drugs
Blog May 11, 2023
Mainland China’s regulatory evolution brings greater access to novel drugs